Pestalozzi advised Adragos Pharma in the Acquisition of Baccinex
Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, Germany, acquired Baccinex, a leading expert in aseptic fill-finish manufacturing based in Courroux, Jura, Switzerland. With this acquisition, Adragos Pharma strengthens its sterile manufacturing capabilities with specialized expertise in aseptic fill-finish and lyophilization.
The addition of Baccinex marks Adragos' 6th global manufacturing site, enhancing its ability to serve clinical and commercial pharmaceutical production needs worldwide.
Pestalozzi advised Adragos Pharma on Swiss law aspects of the transaction with a multi-disciplinary team.